Cross-border regulatory collaborations, such as the five-country ACCESS Consortium, are crucial in meeting the growing challenges posed by increased globalization in health care, according to Canada’s medicines regulator, Health Canada.
“Looking forward, international collaboration between trusted regulators will be key to improving patient access to novel medicines,” a spokesperson for...








